Title

Two-component covalent inhibitor

Authors

Authors

E. M. Cornett; Y. V. Gerasimova;D. M. Kolpashchikov

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Bioorg. Med. Chem.

Keywords

Covalent inhibitors; Irreversible inhibitors; Drug design; DNA; polymerase; Enzymes; Nucleotide analogs; Aryl azide; Pyrene; DNA-POLYMERASES; SENSITIZED PHOTOMODIFICATION; BINARY-SYSTEM; DRUG; DESIGN; REPLICATION; AFFINITIES; COMPLEXES; PROTEINS; LINKING; TARGETS; Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, ; Organic

Abstract

Inhibitors that covalently damage proteins or nucleic acids offer great potency, but are difficult to rationally design and suffer from poor specificity. Here we outline a general concept for constructing covalent inhibitors, called the two-component covalent inhibitor (TCCI). The approach takes advantage of two ligand analogs equipped with pre-reactive groups. Binding of the analogs to the adjacent sites of a target biopolymer brings the pre-reactive groups in close proximity and causes their interaction followed by covalent damage of the target. In the present study we used light-activated pre-reactive groups to inactivate a DNA polymerase. It was found that the efficiency of a traditional single-component inhibitor was greatly reduced in the presence of a non-target protein, while the TCCI was not significantly affected. Our findings suggest that TCCI approach has advantages in inactivation of biopolymers in complex multicomponent systems. (C) 2013 Elsevier Ltd. All rights reserved.

Journal Title

Bioorganic & Medicinal Chemistry

Volume

21

Issue/Number

7

Publication Date

1-1-2013

Document Type

Article

Language

English

First Page

1988

Last Page

1991

WOS Identifier

WOS:000316770300040

ISSN

0968-0896

Share

COinS